Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
May 27, 2024
Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita
Natalie Gross, Jana Marketon, Sadegh Mousavi, et al.
Immunology
|
October 24, 2019
Annexin V expression on CD4<sup>+</sup> T cells with regulatory function
Anna-Lena Bollinger, Thomas Bollinger, Jan Rupp, et al.
Biomedicines
|
November 27, 2024
Dexamethasone's Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective
Ottavia Agrifoglio, Anika Kasprick, Natalie Gross, et al.
Frontiers in Immunology
|
October 31, 2025
<i>Bach2</i>-deficient mice are prone to autoimmune pancreatitis but protected from high-fat diet-induced fatty liver disease
Luise Ehlers, Anika Kasprick, Ottavia Agrifoglio, et al.
Frontiers in Medicine
|
September 24, 2021
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
Hannah Zillikens, Anika Kasprick, Colin Osterloh, et al.
The Journal of Pathology
|
August 11, 2023
Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis
Katja Bieber, Siegfried Bezdek, Yask Gupta, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Journal of Autoimmunity
|
August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses
Saeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
May 27, 2024
Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita
Natalie Gross, Jana Marketon, Sadegh Mousavi, et al.
Immunology
|
October 24, 2019
Annexin V expression on CD4<sup>+</sup> T cells with regulatory function
Anna-Lena Bollinger, Thomas Bollinger, Jan Rupp, et al.
Biomedicines
|
November 27, 2024
Dexamethasone's Clinical Efficacy in Experimental Autoimmune Pancreatitis Correlates with a Unique Transcriptomic Signature, Whilst Kinase Inhibitors Are Not Effective
Ottavia Agrifoglio, Anika Kasprick, Natalie Gross, et al.
Frontiers in Immunology
|
October 31, 2025
<i>Bach2</i>-deficient mice are prone to autoimmune pancreatitis but protected from high-fat diet-induced fatty liver disease
Luise Ehlers, Anika Kasprick, Ottavia Agrifoglio, et al.
Frontiers in Medicine
|
September 24, 2021
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
Hannah Zillikens, Anika Kasprick, Colin Osterloh, et al.
The Journal of Pathology
|
August 11, 2023
Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis
Katja Bieber, Siegfried Bezdek, Yask Gupta, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Journal of Autoimmunity
|
August 20, 2024
High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses
Saeedeh Ghorbanalipoor, Kazuko Matsumoto, Natalie Gross, et al.
Page
of 1